How To Pick A Cannabis Consultant Or Lawyer For Your AGCO Retail Dispensary In The Greater Toronto Area Or Ontario

CANADA:  The regulation of cannabis in Canada has come a long way to where it is today. Since the federal legalization took place, it has proven to be an area that is performing relatively well. However, it’s still a sector that’s highly regulated; in essence, a prospective business owner has to go through stringent processes before being granted a license to operate.

To increase your chances of being granted a license, it’s always recommended that a person seeks legal and consultancy assistance. There are several cannabis consultants in the Greater Toronto and Ontario. Choosing one can be the difference between success and failure.

The purpose of a cannabis consultant is to provide their clients with vital information especially in the areas that they are lacking in knowledge. Besides the horticultural aspect of consultancy, a good adviser should also educate potential business owners about the facility design.

The following is a detailed guide that’ll help you with finding the right cannabis lawyer or consultant:

Things to Consider When Choosing a Cannabis Consultant or Lawyer

Given the popularity of the cannabis industry, it’s quite unfortunate to learn that multiple unscrupulous firms have cropped up claiming to be cannabis consultants. To make matters worse, many naive business owners have fallen prey to them. Here’s how you can avoid such pitfalls and pick the right adviser.

Probing the Advisers

When you’ll be looking for the right adviser, it’s very important to thoroughly vet the person. If you notice that a prospective consultant is quite reserved or hesitant in giving you answers, that may be an indication that he or she isn’t worth hiring. Consultants are vastly knowledgeable and are very quick to offer advice. Some of the questions you shouldn’t fail to ask include the number of years they’ve been in the field, relevant credentials and certification, their current and past clients, and the amount of time he or she will dedicate to you.\

Watch out for the red flags

As you search for the most qualified adviser who’d help you, it’s also good to be on the lookout to avoid anything that can potentially ruin your chances of getting a license. Some examples of red flags you should watch out for include; being asked for equity, a consultant who’s reluctant to track time, not being treated as a partner, and avoiding to answer your questions adequately.

Identify your Needs

Before you seek consultancy services, you should first and foremost understand the specific needs of your business venture. This will help you in determining the particular type of consulting you require as well as providing you with a clear picture of the amount you’ll be willing to pay for that service. Due to the complexity of this industry, this area tends to be a field that has many consulting firms. Thus, you should only go for a person who specializes in a particular niche.

On many occasions, business owners find themselves requiring more than one consultancy service. Even though it may appear costly, the person seeking the services will end up gaining a lot in the long run.

Understanding the Consultancy Process

When it comes to cannabis consultancy, different business owners usually have varying needs. The consultancy process tends to follow three fundamental stages.

Problem definition

This stage usually seeks to identify the particular need of the client and how he or she can work along with the consultant to facilitate a successful outcome.

Business Licensing

Apart from facing other startup challenges, acquiring a cannabis license is usually a difficult hurdle on its own. This step involves acquiring the right license for the client’s business.

Compliance 

For your business to remain operational, it should always comply with the set guidelines in the industry. The Consultant’s work at this stage would be to ensure that your business remains compliant and attains profitability

Conclusion

Getting the help of a cannabis adviser or lawyer is a crucial step before anyone begins operating a cannabis retail dispensary. For any consultancy services to work perfectly, there has to be a positive relationship between both parties. Honesty and timely communication can help in cementing a solid relationship. If you’re searching for the appropriate adviser in Greater Toronto or Ontario, be sure the following the guidelines provided above.

FSD Pharma Announces Strategic Investment In Toronto’s Huge Shops

FSD Pharma Announces Strategic Investment in Huge Shops

CANADA: FSD Pharma has completed a strategic investment of $1.3 million or just under 9.9% in Huge Shops, a Toronto-based cannabis retailer. Huge Shops has a strategic alliance with Chairman’s Brands, parent company of Coffee Time, a well-established operator of retail coffee shops with more than 75 locations in Canada and other locations worldwide.

Screenshot 2018-12-20 07.12.47

As part of the investment, Huge Shops has the option to acquire a minimum of ten retail locations under Chairman’s umbrella of properties, and, subject to availability and further negotiation, purchase additional Coffee Time sites. Huge Shops has identified ten initial key locations across Ontario, which meet the company’s strategic objective to become a premiere recreational cannabis supplier.

Under the province’s current model for recreational cannabis, Huge Shops will file expressions of interest with the Alcohol and Gaming Commission of Ontario (AGCO) in the five designated regions across Ontario in order to obtain one of the province’s first retail locations while strengthening its foothold in Canada’s largest market. Huge Shops stores will be branded and operated independently of Coffee Time shops, but the agreement provides access to the Coffee Time’s highly experienced retail management team and large commercial real estate portfolio.

FSD Pharma Executive Co-Chairman and Co-Founder, Anthony Durkacz, says, “Huge Shops’ strategic alliance with Chairman’s Brands enables the company the ability to quickly create a network, with a well-established consumer base, in key demographic areas throughout the province. FSD Pharma, through its investment in Huge Shops, will offer leading cannabis products to consumers in the province.”

As the province rolls out its private retail model, Huge Shops is planning rapid expansion in key markets throughout Ontario to meet its target of operating 75 locations pursuant to the company receiving its retail operator license.

Huge Shops President and Director, Michael Potts, says, “FSD’s investment and our partnership Chairman’s Brands will help us achieve our goal of rapidly reaching Ontario’s 14 million consumers (1), an estimated CAD $2.3 billion opportunity (2). The strategic alliance gives us an advantage by allowing us to avoid cumbersome leasing arrangements, a problem facing many competitors in our industry.”

PRØHBTD Accelerates Growth With Two Office Openings In Canada

Cannabis Lifestyle Media and Brand Platform Expands Operations to Toronto and Vancouver

CANADA: PRØHBTD, a leading cannabis lifestyle media and brand platform, recently opened new offices in Toronto and Vancouver. The first international expansion beyond PRØHBTD’s primary Los Angeles headquarters, the two offices will lead the company’s growth strategy in Canada in advance of the country’s legalization of the recreational cannabis market on October 17.

The team of six staffers, situated in Toronto’s Liberty Village and downtown Vancouver, are led by Shelley Madison, Senior Producer; David Brott, Director of Brand Partnerships; and Joel Yatscoff, Senior Product Designer. Madison leads all creative content production while Brott leads the company brand partnership efforts, and Yatscoff is responsible for product design and packaging innovation.

“We already work with a number of brand partners across the border so it was a logical expansion to support those efforts,” said PRØHBTD CEO Drake Sutton-Shearer. “We have built our reputation on creating premium cannabis content and helping companies develop their brands, and to now expand these offerings directly in the Canadian market is an important next step in our journey to taking the company public.”

Shelley Madison has more than a decade of experience in the media industry with a focus on creative partnerships, storytelling and content production. Working as both an Executive Producer and Producer, Shelley has collaborated directly on films with Academy Award winning actors and directors including James Franco, Margot Robbie, Nicole Kidman, Robert Pattinson, Werner Herzog and more.

Before joining the PRØHBTD team, Joel Yatscoff founded Burning Tree, a consultancy that specialized in supporting cannabis companies with packaging and labeling. Additionally, he was Head of Product Development at HIKU Brands (recently acquired by Canopy) where he re-imagined products for the Tokyo Smoke and Van der Pop brands. His projects have been recognized internationally including for the prestigious XPRIZE and James Dyson Awards.

David Brott has successfully spearheaded marketing and sales departments within creative agencies, large tech corporations and startups in Toronto, Vancouver, Los Angeles and Taiwan, selling to decision makers in Fortune 1000 companies around the world.

The expansion follows PRØHBTD’s series A round of funding, which secured USD $8 million from investors that included Ontario’s Serruya Private Equity and The Delavaco Group. It represented the single largest round of funding for a media related company in the cannabis industry to date. In addition to the Canada office openings, the funding has accelerated the production and distribution of PRØHBTD’s slate of original content, and deepened the expertise and capabilities across the company through soon to be announced new executive hires.

Tilray Exports 2:100 CBD Oil To The United Kingdom

CANADA: Tilray, a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need.  
 
The changing regulatory measures in the United Kingdom (UK) previously prohibited the use of medical cannabis. However, in July 2018, Home Secretary Sajid Javid announcedthat clinicians will now legally be able to prescribe cannabis-derived medicines to patients with an exceptional clinical need noting “recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory.”
 
With government-approved compassionate access, the UK-based patient suffering from a rare form of epilepsy, now has reliable access to Tilray 2:100, the product used as the primary medicine in a clinical trial testing the efficacy and tolerability of cannabis-derived medicine as treatment for pediatric epilepsy. The trial was conducted in partnership with The Hospital For Sick Children (SickKids) in Toronto, Canada and published promising results in August.
 
In a press release issued by SickKids, Dr. Blathnaid McCoy, Staff Neurologist at SickKids who conducted the clinical trial and authored the research, said “In the participants who reached the target treatment dose we saw a statistically significant reduction in motor seizures, and an increase in seizure-free days compared to those who did not reach the target dose. We observed promising clinically beneficial effects including a reduction in seizure frequency and improvements in certain aspects of adaptive functioning and quality of life measures.”
 
The Tilray oral solution imported to the United Kingdom contains 100 mg/ml cannabidiol (CBD) and 2mg/ml tetrahydrocannabinol (THC), the same ratio of active cannabinoids Tilray used in the recent clinical trial led by SickKids. This ratio of the active cannabinoids was selected after Tilray conducted extensive research on published data of cannabinoids to treat seizures. Tilray 2:100 was deemed safe and well tolerated in pediatric patients by the researchers.

High Park Farms Receives Cannabis Cultivation License From Health Canada

CANADA:  High Park Farms announced that it has received a federal license from Health Canada to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The High Park Farms facility, which is anticipated to represent an investment of up to $30 million, features 13 acres of greenhouse on 100 acres of property in Enniskillen, Ontario.

“This license is a major milestone for High Park as we work to prepare for the anticipated launch of the world’s largest federally legal cannabis market later this year,” said Adine Carter, Chief Marketing Officer of High Park.

High Park Farms will begin cultivating cannabis plants in its greenhouse next week and anticipates its first harvest in June. In accordance with the Cannabis Act introduced in Canadian parliament in April 2017, High Park Farms anticipates that its ACMPR cultivation license will provide the company the ability to supply the adult-use cannabis market in Canada once the legislation is adopted.

High Park launched earlier this month to produce and distribute a broad-based portfolio of cannabis brands and products for the Canadian market in anticipation of adult-use legalization. Based in Toronto and led by a team with deep experience in cannabis and global consumer brands, High Park has secured the exclusive rights to produce and distribute a broad-based portfolio of adult-use cannabis brands and products in Canada, subject to applicable laws and regulations. In addition, High Park has developed new brands and products for the Canadian market. Pending federal legalization of cannabis for adult-use and corresponding provincial legislation, High Park anticipates fulfilling adult-use supply agreements in QuebecManitoba, and Yukon. High Park plans to secure additional supply agreements with crown corporations and private entities in other provinces in the coming months.

Up Cannabis’ Niagara Facility Licensed For Cultivation

CANADA: Up Cannabis has received a producer’s license to cultivate its 160,000 sq. ft. automated greenhouse site in the Niagara region.  The license has a term of three-years and permits production at the Niagara Facility by Up Cannabis of:

  • Dried and fresh Marihuana;
  • Marihuana plants and seeds;
  • Cannabis in its natural form: Cannabis Resin; and,
  • Cannabis oil (bottled).

Cultivation is expected to begin at the Niagara Facility during the current month of April 2018 with the first harvest to take place in the third quarter of 2018.  Production at the existing greenhouse is expected to reach the forecasted annual capacity of approximately 12,500 kg by the end of 2018.

“The receipt of this cultivation license marks the achievement of another critical milestone and showcases the ability of our production team to move from concept to cultivation effectively and quickly”, stated Jay Wilgar, Newstrike’s CEO.  “In just over eight months, we acquired, financed, engineered, permitted, retrofitted and now licensed this fully-automated greenhouse facility and, in doing so, we expect to have aggregate annual production capacity of approximately 15,000 kg coming online for the opening of the Canadian adult-use cannabis market.”

The receipt of the License relates to the existing and recently retrofitted greenhouse operation in Ontario’s Niagara Region.  As previously disclosed, Up Cannabis has received all land-use and related construction permits and expects to break-ground in the second half of 2018 to expand the Niagara Facility by adding an additional 160,000 sq. ft. of cultivation space as well as enhanced processing, packaging, shipping, storage and administrative facilities.   On completion of this planned expansion to the Niagara Facility, Up Cannabis’ aggregate annual production capacity is expected to increase to approximately 27,500 kg.

Insurance Coverage For Medical Marijuana On The Horizon, Industry Experts Say

CANADA: Canadians who have been prescribed medical marijuana could one day see their insurance company footing the bill, experts predict, following the introduction of new Health Canada rules that allow for the sale of cannabis oils.

Health Canada announced revamped medical marijuana regulations earlier this month after the Supreme Court of Canada ruled that users of the drug should be permitted to consume it in other forms, such as oils and edibles, rather than having to smoke dried buds.

“You’re going to see insurance companies slowly start to creep into the sector,” says Khurram Malik, an analyst at Jacob Securities Inc., noting that the new regulations will allow medical marijuana producers to sell gel caps similar to those made from cod liver oil.

That will allow for more precise dosing, Malik says.

“When you’re trying to smoke a plant you have no idea how much you’re consuming, so that makes doctors a little nervous,” he said.